We used the mouse MHC class I p15E tetramer, which recognizes a tumor antigen expressed by MC38 cells, to demonstrate a dose-dependent increase in the percentage of infiltrating tumor antigen-specific CD8+ T cells (Fig. 5g). The gene discussed is CD8A; the disease is neoplasm.